In our study, advanced III and IV stage LSCC patients had a dramatically higher BCL11A SNP OR than did those in initial I and II stage LSCC (Table 3); and the rs4671393 AG/GG genotypes increased the risk of lymph node metastasis (Table 4). Here, BCL11A is linked to metastatic malignant neoplasm in the lymph nodes.